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Abstract
Although more sophisticated ways exist to analyze TG-MS than that applied in our study, the
approach was able to identify the TG species sufficiently to emphasize the importance of TG
structure. The criticism that differences in dietary fat saturation alone would explain the lipoprotein
response across diets is not supported by careful scrutiny of the facts. Nor does fat saturation per
se address the observed impact that fat structure had on insulin/glucose metabolism.
Title. Reply to Destaillats: Interesterified fats to replace
trans fat.
Dear Editor,
The letter from Destaillats et al [1] takes issue with the
design of our recent study [2], suggesting that we failed to
run a true test of fatty acid exchanges that would account
for differences in fat saturation between the three fats
tested. In addition they suggest that our analysis of TG-MS
may lack rigor. If our only objective was simply to match
fatty acid exchanges to generate fats with identical melt
points, their argument concerning design would be well
taken. But, in fact, our intention was broader in scope as
we wished to examine three types of fat products (a natu-
ral saturated fat, POL; one enriched with TFA, PHSO; and
an interesterified fat, IE, enriched with 18:0) that are used
in certain product formulations where a relatively high
degree of solid fat is required. These three fats contained
rough approximations for both total SFA+TFA (12–
18%en) and PUFA (3.5–7 %en). Not only was the FA
exchange of interest, but the structure of TG was a consid-
eration, as well, because both partial hydrogenation and
IE processing modify fat molecular structure. The critique
[1] essentially ignores the TG structure issue, even though
structure repeatedly surfaces as the most logical explana-
tion for results observed.
On the matter of TG-MS analysis, they are correct to indi-
cate that pancreatic lipase, Grignard reagent, mass-spec-
trometry, or NMR have been utilized successfully in the
past. However, our reported HPLC coupled to a ELSD
(Evaporative Light Scatter Detector) method allowed us to
detect the major TG molecules reported, whereas mass
spec would be more appropriate when separation of two
TG regio-isomers is essential. Despite this limitation, our
observations and conclusion about the possible influence
of TG structure on plasma lipoproteins, glucose and insu-
lin are not invalidated. Our cited technique is commonly
used by industry to generate basic TG isomer profiles
when assessing functionality of fats. It allows adequate
discrimination of TG species provided peaks are matched
with authentic TG-MS standards. In continuing analysis,
plasma TG samples from this study were analyzed for
their sn-2 fatty acid content using pancreatic lipase, TLC
separation, and GC-fatty acid analysis. A striking and sig-
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nificant increase in the sn-2 stearic acid was observed fol-
lowing consumption of the IE fat compared to both other
dietary treatments (unpublished), confirming our point
that formation of TG-MS with sn2 stearic acid during
preparation of IE fat carried over to the metabolism of this
fat.
Their additional point that differences in total saturated
fatty acids between diets would explain differences in LDL
and HDL does not adequately account for our observa-
tions for several reasons. First, although IE had more total
SFA than POL or PHSO, most of this was as 18:0, which is
generally deemed to be neutral, or even cholesterol lower-
ing, if we accept their added reference [3] as part of the
argument. If 18:0 is neutral or cholesterol-lowering, then
it seems illogical to include it among the SFA, which they
suggest is the reason that LDL was higher during IE fat
intake, ie. because IE contained more SFA than POL. Pal-
mitic acid, which has been described as the most choles-
terol-raising [3], was much greater in our POL diet, yet
produced the lowest LDL and highest HDL. They also
acknowledge that the Mensink et al regression analysis [4]
failed to account for the lower HDL level during IE con-
sumption. But Thijessen and Mensink [3] specifically
point out that in relation to IE fats "..it is possible that the
effects of natural fats rich in stearic acid on the serum lipo-
protein profile are different from those of synthetic fats".
Thus, the application of regression analysis is suspect at
best under conditions of IE fat consumption. Further-
more, the IE diet had twice the amount of PUFA as the
POL diet, which by most counts and regression analyses
would clearly favor LDL-cholesterol lowering by IE [5]. So
if IE and TFA begin to look alike in their metabolic out-
comes yet differ from POL, and if said differences cannot
be traced to fatty acid saturation/unsaturation, it seems
most likely that interesterification with 18:0 and TG struc-
ture in general are problematic here, not fatty acid satura-
tion. Our interpretation simply attempted to emphasize
this point.
Finally and more importantly, the focus on lipoproteins
and fat saturation misses the real message in our report, ie.
modifying TG structure by IE or partial hydrogenation is
seemingly able to alter glucose and insulin metabolism in
a surprisingly short period relative to a natural saturated
fat. The alteration may be most dramatic in the extreme,
as observed with the IE fat fed here. Further evaluation
seems warranted because IE fats continue to raise ques-
tions about atypical outcomes, whether it be when inter-
preting a regression analysis involving 18:0 and the
lipoprotein response [3] or the plasma glucose/insulin
outcomes reported in our study. We agree that it would be
nice if others, such as the authors of the letter, were to test
additional hypotheses involving IE, including that which
they suggest. With enough studies it should be possible to
determine at what level IE fats become a problem meta-
bolically.
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